Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.010 AlteredExpression disease BEFREE BMI, fasting insulin (FINS), and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), tumor necrosis factor-α (TNF-α) and total testosterone (TT) were significantly changed in both groups, while interleukin (IL)-6, IL-8 and C-reactive protein were changed significantly only in the AN group. 30724385 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 AlteredExpression disease BEFREE Moreover, FINS, HOMA-IR, TT and IL-6 levels were changed more in the AN group than those in the OB group. 30724385 2019
Entrez Id: 3002
Gene Symbol: GZMB
GZMB
0.010 Biomarker disease BEFREE Hyperinsulinemia was detected in one patient with CGL4 and three patients with CGL1, these three CGL1 patients also had acanthosis nigricans. 31778856 2019
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.010 AlteredExpression disease BEFREE BMI, fasting insulin (FINS), and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), tumor necrosis factor-α (TNF-α) and total testosterone (TT) were significantly changed in both groups, while interleukin (IL)-6, IL-8 and C-reactive protein were changed significantly only in the AN group. 30724385 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 Biomarker disease BEFREE BMI, fasting insulin (FINS), and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), tumor necrosis factor-α (TNF-α) and total testosterone (TT) were significantly changed in both groups, while interleukin (IL)-6, IL-8 and C-reactive protein were changed significantly only in the AN group. 30724385 2019
Entrez Id: 26073
Gene Symbol: POLDIP2
POLDIP2
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 1398
Gene Symbol: CRK
CRK
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 57104
Gene Symbol: PNPLA2
PNPLA2
0.010 AlteredExpression disease BEFREE The higher levels of pigment epithelium-derived factor in those with acanthosis nigricans compared with those without, with similar levels of resistance, suggest that pigment epithelium-derived factor levels are associated with acanthosis nigricans. 22288782 2012
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 10598
Gene Symbol: AHSA1
AHSA1
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 7965
Gene Symbol: AIMP2
AIMP2
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 9402
Gene Symbol: GRAP2
GRAP2
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 5176
Gene Symbol: SERPINF1
SERPINF1
0.010 AlteredExpression disease BEFREE The higher levels of pigment epithelium-derived factor in those with acanthosis nigricans compared with those without, with similar levels of resistance, suggest that pigment epithelium-derived factor levels are associated with acanthosis nigricans. 22288782 2012
Entrez Id: 25897
Gene Symbol: RNF19A
RNF19A
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
0.010 Biomarker disease BEFREE The demonstration of a pathogenic role for p38 activation may lead to the development of therapeutic strategies for BSS and related conditions, such as acanthosis nigricans or craniosynostosis. 22585574 2012
Entrez Id: 9882
Gene Symbol: TBC1D4
TBC1D4
0.010 GeneticVariation disease BEFREE A female presenting at age 11 years with acanthosis nigricans and extreme postprandial hyperinsulinemia was heterozygous for a premature stop mutation (R363X) in TBC1D4. 19470471 2009
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.010 Biomarker disease BEFREE The group with AN (n = 30) had higher values for percent overweight, BMI, waist circumference, fasting insulin, HOMA-R, leptin and PAI-1 than the AN-negative group (n = 40), but there were no significant differences in age, sex or percent body fat between the two groups. 16449022 2006
Entrez Id: 2260
Gene Symbol: FGFR1
FGFR1
0.010 GeneticVariation disease BEFREE Two other FGFRs, FGFR1 and FGFR3, also account for craniosynostoses of variable severity [Pfeiffer, Crouzon with acanthosis nigricans (a pre-malignant skin disorder), and Muenke syndromes]. 14987407 2003
Entrez Id: 4914
Gene Symbol: NTRK1
NTRK1
0.010 Biomarker disease BEFREE However, more direct evidence for abnormal tyrosine kinase receptor signalling in AN has been provided by studies of craniosynostosis and skeletal dysplasia syndromes with AN, which have identified activating mutations in fibroblast growth factor receptors. 12452857 2002
Entrez Id: 3480
Gene Symbol: IGF1R
IGF1R
0.010 AlteredExpression disease BEFREE The mechanism of AN due to insulin resistance is most probably direct or indirect activation of the insulin-like growth factor 1 receptor by high levels of circulating insulin. 12452857 2002
Entrez Id: 3791
Gene Symbol: KDR
KDR
0.010 Biomarker disease BEFREE Indirect evidence suggests a role for tyrosine kinase growth factor receptor signalling in the pathogenesis of AN. 12452857 2002
Entrez Id: 3630
Gene Symbol: INS
INS
0.010 Biomarker disease BEFREE For our patients, clinical features are most helpful in differentiating NIDDM-Y from IDDM and include ethnic background, age and gender at diagnosis (approximately 80% of First Nation patients from northern Manitoba are adolescent females), presence of obesity and acanthosis nigricans, lack of symptoms or weight loss, and strong family history of NIDDM. 9492113 1998
Entrez Id: 3875
Gene Symbol: KRT18
KRT18
0.010 AlteredExpression disease BEFREE In contrast to psoriatic tissue, basal keratinocytes of the AN showed an unusually high expression of keratin 18 and 19 protein. 7689823 1993
Entrez Id: 5111
Gene Symbol: PCNA
PCNA
0.010 Biomarker disease BEFREE With regard to keratin 6 mRNA, and the protein expression of keratin 6/16, KI-67, and proliferating cell nuclear antigen, the AN lesion showed moderate hyperproliferation. 7689823 1993
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.010 Biomarker disease BEFREE Since there is no other report describing the link between TGF-alpha and acanthosis nigricans, except that of Ellis et al. 1444575 1992